Bravetti Giorgio Enrico

Bravetti Giorgio Enrico, Gillmann Kevin, Salinas Lauriane, Berdahl John P, Lazcano-Gomez Gabriel S, Williamson Blake K et al.

KDB goniotomy for severe glaucoma significantly lowered IOP and medication use over 12 months, showing good safety. This offers a useful treatment option for high-risk eyes.

Gillmann Kevin, Bravetti Giorgio Enrico, Rao Harsha L, Mermoud André, Mansouri Kaweh

XEN gel stent implantation significantly lowered IOP and medication use at 3 years for glaucoma, despite needing frequent revisions. Identifying high-risk patients preoperatively is crucial.

Bravetti Giorgio Enrico, Mansouri Kaweh, Gillmann Kevin, Rao Harsha L, Mermoud André

XEN-augmented Baerveldt implants moderately reduced IOP in refractory glaucoma, but 41.5% required reoperation within a year, indicating limited long-term success despite initial IOP reduction.